|
Volumn 50, Issue 11, 2009, Pages 1750-1752
|
Current clinical evidence on interim fluorine-18 fluorodeoxy glucose positron emission tomography for advanced-stage Hodgkin lymphoma and diffuse large B-cell lymphoma to predict treatment outcomes
|
Author keywords
Diffuse large B cell lymphoma; FDG PET; Hodgkin lymphoma; Interim response assessment; Prognosis
|
Indexed keywords
FLUORODEOXYGLUCOSE F 18;
CLINICAL PRACTICE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
HODGKIN DISEASE;
HUMAN;
LARGE CELL LYMPHOMA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
SYSTEMATIC REVIEW;
TREATMENT FAILURE;
TREATMENT OUTCOME;
FLUORODEOXYGLUCOSE F18;
HODGKIN DISEASE;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
NEOPLASM STAGING;
POSITRON-EMISSION TOMOGRAPHY;
PROGNOSIS;
REPRODUCIBILITY OF RESULTS;
TREATMENT OUTCOME;
|
EID: 71049138914
PISSN: 10428194
EISSN: 10292403
Source Type: Journal
DOI: 10.3109/10428190903308080 Document Type: Conference Paper |
Times cited : (6)
|
References (7)
|